PRDX6 and polycystic ovary syndrome: In short, circulating proteins such as PRDX6, FN1 and SERPINB9 provide further clues for exploring the effective molecular mechanism of treatment and might be reference candidate biomarkers for assisting with choosing the most suitable drugs for overweight/obese PCOS patients.